NES
AMPE

New England Securities’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

New England Securities’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$3K Buy
+3
New +$3.21K ﹤0.01% 1417

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New England Securities's AMPE Position: Q4 2014 in Review

New England Securities opened a new position in Ampio Pharmaceuticals Inc. (AMPE) in Q4 2014: 3 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #1417 among its holdings.

69 funds tracked by Wall St. Rank hold AMPE as of Q4 2014.

  • New England Securities held 3 shares of Ampio Pharmaceuticals Inc. worth $3K as of Q4 2014.
  • Ampio Pharmaceuticals Inc. was a new New England Securities position in Q4 2014.
  • Ampio Pharmaceuticals Inc. made up ﹤0.01% of New England Securities's portfolio in Q4 2014, its #1417 holding.
  • 69 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.